We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Commentary |

What Is C-Reactive Protein Telling Us About Coronary Artery Disease?

Stanley S. Levinson, PhD; Ronald J. Elin, MD, PhD
Arch Intern Med. 2002;162(4):389-392. doi:10.1001/archinte.162.4.389.
Text Size: A A A
Published online


HUMAN C-reactive protein (CRP) was originally observed in the plasma of patients with acute infections and was found to react with the C-polysaccharide of the pneumococcus.1 It is an acute-phase reactant, because of the pronounced rise in concentration after tissue injury or inflammation. This diagnostically sensitive but nonspecific marker for inflammation is produced primarily by the liver but also by lymphocytes.2 C-reactive protein appears to recognize both foreign pathogens and damaged host cells and can initiate their elimination by interacting with humoral and cellular effector systems in the blood.3 The work of Ross and others has clearly shown that arteriosclerosis involves a chronic inflammatory process.4 Thus, it is not surprising that a series of studies have now found a significant positive relationship between CRP concentration and coronary artery disease (CAD),5,6 although it remains unclear that this relationship is independent of other inflammatory markers.7 Hence, a 70-year-old test used to detect acute inflammation has now become a potential important marker for CAD. This commentary raises questions associated with the use of CRP as a screening device for CAD in asymptomatic patients.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

20 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections

Users' Guides to the Medical Literature
An Illustration of Bias and Random Error

Users' Guides to the Medical Literature
An Illustration of Bias and Random Error